Fundz

Fate Therapeutics Inc reported raising $56.7 Million in an initial SEC Form D filing, from an offering of $56.7 Million

PUBLIC · FATEDec 08, 2016

Amount Raised

$56.7 Million

$56.7 Million sold, per SEC Form D (first sale Dec 8, 2016)

Round Type

Venture

San DiegoBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

Fate Therapeutics raised $56.7 Million in a funding round, dated December 8, 2016. Fate Therapeutics is based in San Diego, California, United States.

How much did Fate Therapeutics raise?
Fate Therapeutics raised $56.7 Million in a funding round on December 8, 2016.
What does Fate Therapeutics do?
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class induced pluripotent stem cell (iPSC)-derived cellular immunotherapies.
Where is Fate Therapeutics based and how big is it?
Fate Therapeutics is based in San Diego, California, United States. Fundz records about 190 employees.
Who are the decision-makers at Fate Therapeutics?
Fundz holds 2 contacts at Fate Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Fate Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Cartesian Therapeutics, Inc. raised $5M (Seed) on December 14, 2016.
  • Decoy Therapeutics Inc. raised $132K (Pre-Seed) on November 21, 2016.
  • Rhythm Pharmaceuticals raised $20M on January 20, 2017.
  • Ovid Therapeutics raised $26M on January 20, 2017.
  • BIOVIE INC. raised $200K (Pre-Seed) on January 19, 2017.
  • Galectin raised $3M (Seed) on January 6, 2017.

Who to call at Fate Therapeutics, and when

A new round usually means Fate Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Fate Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fate Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fate Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fate Therapeutics

Location

San Diego, California, United States

About

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class induced pluripotent stem cell (iPSC)-derived cellular immunotherapies. The company aims to provide innovative treatments for patients with cancer and autoimmune disorders. Their pipeline includes advanced cellular therapies that leverage cutting-edge genetic technologies to enhance the efficacy and safety of these therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fate Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts42 people are listed at Fate Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Fate Therapeutics's next move

See what Strategic adds

Fate Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.